60 Degrees Pharmaceuticals, Inc. Warrant reports a Return on Equity (ROE) of -159.81%.

What is SXTPW's dividend yield?

60 Degrees Pharmaceuticals, Inc. Warrant offers a dividend yield of 0.00%.

What is SXTPW's Quality Score?

Our AI rates SXTPW's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SXTPW?

Our AI Timing Score for SXTPW is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SXTPW belong to?

60 Degrees Pharmaceuticals, Inc. Warrant is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

SXTPW AI Analysis Summary

Our AI summary for SXTPW: 60 Degrees Pharmaceuticals, Inc. Warrant (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -159.81%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SXTPW

60 Degrees Pharmaceuticals, Inc. Warrant

US:NASDAQ STOCK Healthcare >> Biotechnology News 75

USD 0.03

-0.01 (-17.65%) Day Change

Watchlist Portfolio Compare Chart

0.03

D/E

-159.8%

ROE

-112.1%

ROA

0.00%

Div Yield

60 DEGREES PHARMACEUTICALS, INC. WARRANT
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.03 Price -0.01 (-17.65%) Day Change	NEWS SCORE: 75

SXTPW, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...

Quality Factors

41%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	75
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.03
PBV / Sector	N/A / 44,105.10
Earning Per Share	N/A

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	186.116680000000
Average 1W Daily Value	76.119820000000 GOOD

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-755.16 / 97.23
NPM Average (%) / Sector	-1,410.39 / -1,697.84
NPM Change Average (%) / Sector	-24.80 / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-112.10 / 185,260.64
ROA Average (%) / Sector	-182.49 / 36,684.64
ROA Change Average (%) / Sector	19.18 / 422,221.42 GOOD
ROE (%) / Sector	-159.81 / 243,761.81
ROE Average (%) / Sector	-126.02 / 48,758.38
ROE Change Average (%) / Sector	-63.27 / 424,967.86
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 08:00:45
Symbol	SXTPW
Name	60 DEGREES PHARMACEUTICALS, INC. WARRANT
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: -

Phone: -

Website: -

Sector: Healthcare >> Biotechnology

Description: 60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.